4.7 Article

The Chromatin-Oxygen Sensor Gene KDM5C Associates with Novel Hypoxia-Related Signatures in Glioblastoma Multiforme

Related references

Note: Only part of the references are listed.
Article Oncology

Tumor-associated macrophage derived IL-6 enriches cancer stem cell population and promotes breast tumor progression via Stat-3 pathway

N. N. Radharani et al.

Summary: Tumor-associated macrophages (TAMs) promote tumor progression by interacting with breast cancer cells, expressing various proteins, including cytokines that enrich cancer stem cells (CSCs). TAMs produce high levels of Interleukin-6 (IL-6) through p38-MAPK pathway upon interaction with breast cancer cells. TAM-derived IL-6 activates Signal transducer and activator of transcription 3 (STAT-3) pathway, promotes CSC enrichment and influences tumor growth in breast cancer.

CANCER CELL INTERNATIONAL (2022)

Review Oncology

Hypoxia as a Modulator of Inflammation and Immune Response in Cancer

Rosa A. Castillo-Rodriguez et al.

Summary: In this review, the association between hypoxia and cancer is analyzed, focusing on the effects of hypoxia on tumoral cells and surrounding cells, as well as the involvement of HIF, NF-kappa B, and STAT signaling pathways. The response of immune cells to hypoxia and potential therapeutic applications are also discussed.

CANCERS (2022)

Article Oncology

NSUN6, an RNA methyltransferase of 5-mC controls glioblastoma response to temozolomide (TMZ) via NELFB and RPS6KB2 interaction

Chidiebere U. Awah et al.

Summary: NSUN6 regulates glioblastoma response to temozolomide through 5mC-mediated regulation of NELFB and RPS6BK2, with high expression conferring survival benefit to patients, opening up a new frontier in understanding the transcriptional regulation by RNA methyltransferase and 5mC.

CANCER BIOLOGY & THERAPY (2021)

Article Chemistry, Multidisciplinary

The Dual Function of KDM5C in Both Gene Transcriptional Activation and Repression Promotes Breast Cancer Cell Growth and Tumorigenesis

Hai-feng Shen et al.

Summary: Research has shown that the epigenetic regulator KDM5C can both activate estrogen receptor alpha (ER alpha) target genes and suppress type I interferons in breast cancer cells, contributing to cell growth and tumorigenesis. This dual activator and repressor function of KDM5C plays a role in cancer development.

ADVANCED SCIENCE (2021)

Article Immunology

Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker

Xin Cheng et al.

Summary: TREM2 is highly expressed in most cancers and is associated with prognosis, tumor mutational burden, microsatellite instability, and DNA methylation. In 6 selected tumor types, TREM2 gene expression was negatively correlated with most immune cell infiltration levels but positively correlated with M1 and M2 macrophages infiltration levels. The correlation with TREM2 expression differed according to T cell subtype.

FRONTIERS IN IMMUNOLOGY (2021)

Review Oncology

The Role of Hypoxia in Glioblastoma Radiotherapy Resistance

Agathe L. Chedeville et al.

Summary: Glioblastoma (GB) is the deadliest type of primary brain tumor with a median survival time of 16 months post-diagnosis, and radiotherapy remains the most effective treatment despite the common resistance observed in GB patients. Understanding the role of low tumor oxygenation (hypoxia) in radioresistance is crucial for developing novel strategies to improve tumor cell sensitivity to radiotherapy.

CANCERS (2021)

Review Cell & Tissue Engineering

Role of glioblastoma stem cells in cancer therapeutic resistance: a perspective on antineoplastic agents from natural sources and chemical derivatives

Ana Laura V. Alves et al.

Summary: Glioblastoma (GBM) is the highest-grade form of glioma, characterized by rapid cellular growth and high invasiveness. Understanding cancer stem cells (CSCs) has provided new insights into GBM resistance and management. With knowledge of GSCs and therapies based on antineoplastic agents, a promising future in GBM treatment may be on the horizon.

STEM CELL RESEARCH & THERAPY (2021)

Article Immunology

Predictive Value of KDM5C Alterations for Immune Checkpoint Inhibitors Treatment Outcomes in Patients With Cancer

Xiao-Juan Chen et al.

Summary: KDM5C alterations are associated with predictive value for cancer patients receiving ICIs, with patients having KDM5C alterations showing better survival rates. KDM5C alterations also correlate with increased tumor immunogenicity and anti-tumor immunity.

FRONTIERS IN IMMUNOLOGY (2021)

Article Multidisciplinary Sciences

Pathogenic variants in SMARCA5, a chromatin remodeler, cause a range of syndromic neurodevelopmental features

Dong Li et al.

Summary: The study reveals pathogenic variants in SMARCA5 as a cause of a previously unidentified neurodevelopmental disorder, leading to mild developmental delay, short stature, microcephaly, and dysmorphic features. Functional experiments in fruit flies confirmed that loss of SMARCA5 function results in abnormal neural development.

SCIENCE ADVANCES (2021)

Review Oncology

IL-10 in glioma

Samuel S. Widodo et al.

Summary: The prognosis for patients with GBM is very poor despite current standard treatments. The immunosuppressive tumour microenvironment hinders the development of effective immunotherapies for GBM, and understanding the role of IL-10 in GBM is crucial for improving immunotherapy.

BRITISH JOURNAL OF CANCER (2021)

Article Multidisciplinary Sciences

SON drives oncogenic RNA splicing in glioblastoma by regulating PTBP1/PTBP2 switching and RBFOX2 activity

Jung-Hyun Kim et al.

Summary: SON is identified as a master regulator in glioblastoma, activating oncogenic splicing mediated by PTBP1 and suppressing non-oncogenic neuronal splicing mediated by RBFOX2. Overexpression of SON in GBM patients leads to failure in intron removal from PTBP1 transcript, resulting in downregulation of PTBP1 and inhibition of its downstream oncogenic splicing.

NATURE COMMUNICATIONS (2021)

Article Genetics & Heredity

Analysis of a Set of KDM5C Regulatory Genes Mutated in Neurodevelopmental Disorders Identifies Temporal Coexpression Brain Signatures

Loredana Poeta et al.

Summary: The dysregulation of transcriptional pathways in neurodevelopmental disorders was shown to be connected to KDM5C and its transcriptional regulators, ARX, PHF8, and ZNF711, whose co-expression in brain areas and cellular sub-types is temporally regulated. Additionally, the interaction between ARX and PHF8 was discovered, and the impact of pathogenic mutations in these genes was tested in lymphoblastoid cell lines from children with syndromic intellectual disability, revealing a direct correlation between the KDM5C-H3K4me3 pathway defects and severity of disability. These results provide new insights into the epigenetic processes related to NDD pathogenesis and potential avenues for treatment.

GENES (2021)

Review Immunology

TREM2: Keeping Pace With Immune Checkpoint Inhibitors in Cancer Immunotherapy

Hui Qiu et al.

Summary: Research indicates that TREM2 plays a crucial role in the tumor microenvironment by inhibiting immune responses, thus impacting the effectiveness of immunotherapy.

FRONTIERS IN IMMUNOLOGY (2021)

Article Oncology

NANOG Promotes Cell Proliferation, Invasion, and Stemness via IL-6/STAT3 Signaling in Esophageal Squamous Carcinoma

Li Deng et al.

Summary: The overexpression of NANOG in esophageal squamous cell carcinoma (ESCC) enhances cell proliferation and stemness by activating the IL-6/STAT3 signaling pathway, which in turn upregulates target genes involved in proliferation and invasion.

TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2021)

Article Medicine, Research & Experimental

Deficiency of the X-inactivation escaping gene KDM5C in clear cell renal cell carcinoma promotes tumorigenicity by reprogramming glycogen metabolism and inhibiting ferroptosis

Qian Zheng et al.

Summary: The histone demethylase gene KDM5C was found to play a crucial role in ccRCC by regulating glucose metabolism and affecting cell tolerance and survival through glycogen synthesis and glucose flux modulation.

THERANOSTICS (2021)

Article Oncology

Multiple microRNAs as biomarkers for early breast cancer diagnosis

Ji Young Jang et al.

Summary: MicroRNAs present in plasma can be used as potential biomarkers for early detection of breast cancer. Combinations of multiple miRNAs show higher accuracy in detecting breast cancer compared to single biomarkers. These miRNA biomarkers are expected to overcome limitations of mammography when used as an auxiliary diagnosis.

MOLECULAR AND CLINICAL ONCOLOGY (2021)

Article Cell Biology

HIF-1 recruits NANOG as a coactivator for TERT gene transcription in hypoxic breast cancer stem cells

Haiquan Lu et al.

Summary: NANOG and HIF-1 cooperatively activate the TERT gene to mediate breast cancer stem cell self-renewal, with NANOG stimulating HIF-1 transcriptional activity by recruiting USP9X and stabilizing the interaction between HIF-1 alpha and p300.

CELL REPORTS (2021)

Review Oncology

The interplay between HIF-1α and noncoding RNAs in cancer

Xiafeng Peng et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)

Review Oncology

Management of glioblastoma: State of the art and future directions

Aaron C. Tan et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Article Biochemistry & Molecular Biology

TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy

Martina Molgora et al.

Review Biochemistry & Molecular Biology

Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer

Luca Colucci-D'Amato et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Multidisciplinary Sciences

Glioma-initiating cells at tumor edge gain signals from tumor core cells to promote their malignancy

Soniya Bastola et al.

NATURE COMMUNICATIONS (2020)

Review Cell Biology

Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance

Dimas Carolina Belisario et al.

CELLS (2020)

Article Hematology

Hypoxia-Mediated Regulation of Histone Demethylases Affects Angiogenesis-Associated Functions in Endothelial Cells

Oscar Hsin-Fu Liu et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)

Review Oncology

Glioblastoma Stem cells: Driving Resilience through Chaos

Briana C. Prager et al.

TRENDS IN CANCER (2020)

Review Oncology

5-ALA and FDA approval for glioma surgery

Constantinos G. Hadjipanayis et al.

JOURNAL OF NEURO-ONCOLOGY (2019)

Article Oncology

JmjC histone demethylases act as chromatin oxygen sensors

Michael Batie et al.

MOLECULAR & CELLULAR ONCOLOGY (2019)

Editorial Material Cell & Tissue Engineering

Building Bonds: Cancer Stem Cells Depend on Their Progeny to Drive Tumor Progression

Sree Deepthi Muthukrishnan et al.

CELL STEM CELL (2018)

Article Neurosciences

Altered Gene-Regulatory Function of KDM5C by a Novel Mutation Associated With Autism and Intellectual Disability

Christina N. Vallianatos et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)

Article Oncology

The p75 neurotrophin receptor enhances HIF-dependent signaling in glioma

Bei Tong et al.

EXPERIMENTAL CELL RESEARCH (2018)

Review Oncology

The role of interleukin-6-STAT3 signalling in glioblastoma

Alice J. West et al.

ONCOLOGY LETTERS (2018)

Review Oncology

Beyond DNA: the Role of Epigenetics in the Premalignant Progression of Breast Cancer

Rebecca S. DeVaux et al.

JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2018)

Article Oncology

Enhancement of Proliferation and Invasion of Gastric Cancer Cell by KDM5C Via Decrease in p53 Expression

Liming Xu et al.

TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2017)

Retraction Medicine, Research & Experimental

撤稿声明: Histone demethylase JARID1C inactivation triggers genomic instability in sporadic renal cancer (Retraction of vol 125, pg 4625, 2015)

Beatrice Rondinelli et al.

JOURNAL OF CLINICAL INVESTIGATION (2016)

Article Biochemistry & Molecular Biology

Expression and Prognostic Significance of p53 in Glioma Patients: A Meta-analysis

Yueling Jin et al.

NEUROCHEMICAL RESEARCH (2016)

Article Biochemistry & Molecular Biology

Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma

Rintaro Hashizume et al.

NATURE MEDICINE (2014)

Review Biotechnology & Applied Microbiology

Histone lysine demethylases as targets for anticancer therapy

Jonas W. Hojfeldt et al.

NATURE REVIEWS DRUG DISCOVERY (2013)

Article Clinical Neurology

Ki-67 overexpression in WHO grade II gliomas is associated with poor postoperative seizure control

Yang Yuan et al.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2013)

Article Genetics & Heredity

De Novo Mutations in MLL Cause Wiedemann-Steiner Syndrome

Wendy D. Jones et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2012)

Review Clinical Neurology

The pathogenesis of tumor-related epilepsy and its implications for clinical treatment

Gan You et al.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2012)

Review Pharmacology & Pharmacy

Targeting survivin in cancer: the cell-signalling perspective

Jagat R. Kanwar et al.

DRUG DISCOVERY TODAY (2011)

Article Multidisciplinary Sciences

Escape from X chromosome inactivation is an intrinsic property of the Jarid1c locus

Nan Li et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Biochemistry & Molecular Biology

The p75 neurotrophin receptor is a central regulator of glioma invasion

Angela L. M. Johnston et al.

PLOS BIOLOGY (2007)

Article Multidisciplinary Sciences

The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation

Mamta Tahiliani et al.

NATURE (2007)

Article Genetics & Heredity

Mutations in autism susceptibility candidate 2 (AUTS2) in patients with mental retardation

Vera M. Kalscheuer et al.

HUMAN GENETICS (2007)

Article Biochemistry & Molecular Biology

Bach1 functions as a hypoxia-inducible repressor for the heme oxygenase-1 gene in human cells

T Kitamuro et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2003)